The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 111, Issue 2, 2011, Pages 153-163

  Wilde, Frank ^a   Heufelder, Marcus ^a   Winter, Karsten ^b   Hendricks, Jrg ^c   Frerich, Bernhard ^d   Schramm, Alexander ^a   Hemprich, Alexander ^c  

^a UNIVERSITY OF ULM   (Germany)

^b Translational Centre for Regenerative Medicine   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ARTICLE; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAW DISEASE; MALE; MANDIBLE; MAXILLA; METHODOLOGY; ORAL SURGERY; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; JAW DISEASES; MALE; MANDIBLE; MAXILLA; ORAL SURGICAL PROCEDURES; OSTEONECROSIS; TREATMENT OUTCOME;

EID: 78651425485     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.04.015     Document Type: Article

References (35)

1. R.E. Marx Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis: a growing epidemic J Oral Maxillofac Surg 61 2005 1115 1118
2. A.-V. Keck, and M. Pecherstorfer Knochenstoffwechsel bei malignen Erkrankungen Journal fr Mineralstoffwechsel 10 2003 6 11
3. P. Schmid Pharmakologie der Bisphosphonate P. Schmid, K. Possinger, Supportive Therapie von Knochenmetastasen 2005 Uni-Med Science Bremen 78 88
4. R.E. Marx Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention and treatment 2007 Quintessence Books Hanover Park, IL
5. S.L. Ruggiero, J. Fantasia, and E. Carlson Bisphosphonate-related osteonecrosis of the jaw Background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2006 433 444
6. American Association of OralMaxillofacial Surgeons (AAOMS) Position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
7. American Association of Oral and Maxillofacial Surgeons (AAOMS) Position paper on bisphosphonate-related osteonecrosis of the jaw2009 Update http://www.aaoms.org/docs/position-papers/bronj-update.pdf Accessed August 25, 2009
8. B. Al-Nawas, K.A. Grtz, and J.-U. Piesold Leitliniengruppe Septische Chirurgie" der DGMKG. AWMF-Leitlinien-Register Nr. 007/ 091: Leitlinienentwurf: "Bisphosphonat-assoziierte Kiefernekrosen." http://www.uni-duesseldorf.de/awmf/ 2007 Accessed September 14, 2007
9. L. Montebugnoli, L. Felicetti, D.B. Gissi, A. Pizzigallo, G.A. Pelliccioni, and C. Marchetti Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 2007 473 477
10. A.A. Khan, G.K. Sndor, E. Dore, A.D. Morrison, M. Alsahli, and F. Amin Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw J Rheumatol 35 2008 1391 1397
11. A.A. Khan, G.K. Sndor, E. Dore, A.D. Morrison, M. Alsahli, and F. Amin Bisphosphonate associated osteonecrosis of the jaw J Rheumatol 36 2009 478 490
12. A. Wutzl, E. Biedermann, F. Wanschitz, R. Seemann, C. Klug, and A. Baumann Treatment results of bisphosphonate-related osteonecrosis of the jaws Head Neck 30 2008 1224 1230
13. M.H. Abu-Id, P.H. Warnke, J. Gottschalk, I. Springer, J. Wiltfang, and Y. Acil "Bis-phossy jaws"high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw J Craniomaxillofac Surg 36 2008 95 103
14. C. Pautke, F. Bauer, T. Tischer, K. Kreutzer, J. Weitz, and M. Kesting Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 471 476
15. E.R. Carlson, and J.D. Basile The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 85 95
16. P. Stockmann, E. Vairaktaris, F. Wehrhan, M. Seiss, S. Schwarz, and B. Spriewald Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up Support Care Cancer 18 2010 449 460
17. American Society of Anaesthesiologists (ASA) ASA Physical Status Classification System http://www.asahq.org/clinical/physicalstatus.htm 2009 Accessed July 2, 2009
18. S.D. Bianchi, M. Scoletta, F.B. Cassione, G. Migliaretti, and M. Mozzati Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 2007 249 258
19. S. Chiandussi, M. Biasotto, F. Cavalli, M.A. Cova, and R. Di Learda Clinical and diagnostic imaging of bisphosphonte-associated osteonecrosis of the jaws Dentomaxillofac Radiol 35 2006 236 243 (Pubitemid 44076879)
20. F. Wilde, K. Steinhoff, B. Frerich, A. Hemprich, O. Sabri, and R. Kluge Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 412 419
21. J.M. Fullmer, W.C. Scarfe, G.M. Kushner, B. Alpert, and A.G. Barman Cone beam computed tomographic findings in refractory chronic suppurative osteomyelitis of the mandible Br J Oral Maxillofac Surg 745 2007 364 371
22. F. Wilde, E. Hirsch, M. Heufelder, B. Frerich, and A. Hemprich 3 D Volumentomographie in der Diagnostik und Operationsplanung bei Bisphosphonat assoziierten Kieferknochennekrosen Journal der Deutschen Gesellschaft fr Plastische und Wiederherstellungschirurgie 20 2008 28 30
23. S. Kottal, and K. Fleisher Evaluation of radiographic findings in conebeam computed tomography volumes of patients with bisphosphonate induced osteonecrosis of the jaws Int J CARS 4 Suppl 1 2009 216
24. D. Schulze, M. Heiland, H. Thurmann, and G. Adam Radiation exposure during midfacial imaging using 4- and 16-slice computed tomography, cone beam computed tomography systems and conventional radiography Dentomaxillofac Radiol 33 2009 83 86
25. E. Coppenrath, F. Draenert, U. Lechel, R. Veit, T. Meindl, and M. Reiser Schnittbildverfahren zur dentomaxillofazialen Diagnostik: Dosisvergleich von Dental-MSCT und NewTom® 9000 DVT Cross-Sectional Imaging in Dentomaxillofacial Diagnostics: Dose Comparison of Dental MSCT and NewTom® 9000 DVT Fortschr Rntgenstr 180 2008 396 401
26. T. Hansen, M. Kunkel, A. Weber, and C.J. Kirkpatrick Osteonecrosis of the jaws in patients treated with bisphosphonateshistomorphic analysis in comparison with infected osteoradionecrosis J Oral Pathol Med 35 2006 155 160
27. A. Bedogni, S. Blandamura, Z. Lokmic, C. Palumbo, M. Ragazzo, and F. Ferrari Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 2008 358 364
28. J.-U. Piesold, B. Al-Navas, and K.A. Grtz Osteonekrose der Kiefer unter Bisphosphonat-Langzeittherapie Mund Kiefer Gesichtschir 10 2006 287 300
29. C. Magopoulos, G. Karakinaris, Z. Telioudis, K. Vahtsevanos, I. Dimitrakopoulos, and K. Antoniadis Osteonecrosis of the jaws due to bisphosphonate use A review of 60 cases and treatment proposals Am J Otolaryngol 28 2007 158 163
30. P. Conte, and V. Guarneri Safety of intravenous and oral bisphosphonates and compliance with dosing regimens Oncologist 9 2004 28 37
31. J.R. Ross, Y. Saunders, P.M. Edmonds, S. Patel, D. Wonderling, and C. Normand A systematic review of the role of bisphosphonates in metastatic disease Health Technol Assess 8 2004 1 176
32. R.E. Coleman Risks and benefits of bisphosphonates Br J Cancer 98 2008 1736 1740
33. V.M. Cartsos, S. Zhu, and A.I. Zavras Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people J Am Dent Assoc 139 2008 23 30
34. K.H. Rateitschak, E.M. Rateitschak, and H.F. Wolf Parodontologie, Farbatlanten der Zahnmedizin 1 2. Auflage 1989 Thieme Stuttgart 158
35. W. Forth, D. Henschler, W. Rummel, and K. Starke Allgemeine und spezielle Pharmakologie und Toxikologie 6. Auflage 1996 Spektrum Akademischer Verlag Heidelberg 613 721